Growth Metrics

Amphastar Pharmaceuticals (AMPH) Interest & Investment Income (2016 - 2025)

Historic Interest & Investment Income for Amphastar Pharmaceuticals (AMPH) over the last 13 years, with Q3 2025 value amounting to $2.2 million.

  • Amphastar Pharmaceuticals' Interest & Investment Income fell 745.78% to $2.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $8.5 million, marking a year-over-year decrease of 1953.31%. This contributed to the annual value of $10.6 million for FY2024, which is 9439.46% up from last year.
  • Per Amphastar Pharmaceuticals' latest filing, its Interest & Investment Income stood at $2.2 million for Q3 2025, which was down 745.78% from $1.9 million recorded in Q2 2025.
  • In the past 5 years, Amphastar Pharmaceuticals' Interest & Investment Income ranged from a high of $3.3 million in Q2 2024 and a low of $141000.0 during Q3 2021
  • Moreover, its 5-year median value for Interest & Investment Income was $1.0 million (2023), whereas its average is $1.3 million.
  • Its Interest & Investment Income has fluctuated over the past 5 years, first soared by 41049.72% in 2023, then plummeted by 4243.33% in 2025.
  • Quarter analysis of 5 years shows Amphastar Pharmaceuticals' Interest & Investment Income stood at $157000.0 in 2021, then soared by 269.43% to $580000.0 in 2022, then surged by 297.07% to $2.3 million in 2023, then fell by 0.48% to $2.3 million in 2024, then dropped by 2.01% to $2.2 million in 2025.
  • Its Interest & Investment Income stands at $2.2 million for Q3 2025, versus $1.9 million for Q2 2025 and $2.1 million for Q1 2025.